Citations for
1ADRB1, ADRB2, ADRB3
Differential S-palmitoylation of the human and rodent β3-adrenergic receptor.
Adachi N, Hess DT, Kaku M, Ueda C, Numa C, Saito N.
J Biol Chem Biol Chem. 2018 Dec 12. pii: jbc.RA118.004978. doi: 10.1074/jbc.RA118.004978. [Epub ahead of print] 2018
2ADRB3
Decrease of the DNA methylation levels of the ADRB3 gene in leukocytes is related with serum folate in eutrophic adults.
de Oliveira Y, Lima RPA, Luna RCP, Monteiro MGCA, da Silva CSO, do Nascimento RAF, de Farias Lima KQ, Andrade E Silva AH, de Lima Ferreira FEL, de Toledo Vianna RP, de Moraes RM, de Oliveira NFP, de Almeida ATC, Silva AS, da Silva Diniz A, de Carvalho Costa MJ, da Conceição Rodrigues Gonçalves M.
J Transl Med 16(1):152. doi: 10.1186/s12967-018-1529-0. 2018
3ADRB3, BORCS6
A Stat6/Pten Axis Links Regulatory T Cells with Adipose Tissue Function.
Kälin S, Becker M, Ott VB, Serr I, Hosp F, Mollah MMH, Keipert S, Lamp D, Rohner-Jeanrenaud F, Flynn VK, Scherm MG, Nascimento LFR, Gerlach K, Popp V, Dietzen S, Bopp T, Krishnamurthy P, Kaplan MH, Serrano M, Woods SC, Tripal P, Palmisano R, Jastroch M, Blüher M, Wolfrum C, Weigmann B, Ziegler AG, Mann M, Tschöp MH, Daniel C.
Cell Metab 26(3):475-492.e7. doi: 10.1016/j.cmet.2017.08.008. 2017
4ADRB3
Distinct cellular and molecular mechanisms for β3 adrenergic receptor-induced beige adipocyte formation.
Jiang Y, Berry DC, Graff JM.
Elife 6. pii: e30329. doi: 10.7554/eLife.30329. 2017
5ADRB3, APOA1
β3-Adrenergic receptor regulates hepatic apolipoprotein A-I gene expression.
Cao X, Li Y.
J Clin Lipidol 11(5):1168-1176. doi: 10.1016/j.jacl.2017.07.007. Epub 2017 Jul 27. 2017
6ADRB3
Beta3 adrenergic receptor stimulation in human macrophages inhibits NADPHoxidase activity and induces catalase expression via PPARγ activation.
Hadi T, Douhard R, Dias AMM, Wendremaire M, Pezzè M, Bardou M, Sagot P, Garrido C, Lirussi F.
Biochim Biophys Acta Mol Cell Res 1864(10):1769-1784. doi: 10.1016/j.bbamcr.2017.07.003. Epub 2017 Jul 16. 2017
7ADRB3
β3-Adrenergic Regulation of EPC Features Through Manipulation of the Bone Marrow MSC Niche.
Vafaei R, Nassiri SM, Siavashi V.
J Cell Biochem 118(12):4753-4761. doi: 10.1002/jcb.26143. Epub 2017 Jun 12. 2017
8ADRB3
The β3-adrenergic receptor is dispensable for browning of adipose tissues.
de Jong JMA, Wouters RTF, Boulet N, Cannon B, Nedergaard J, Petrovic N.
Am J Physiol Endocrinol Metab 312(6):E508-E518. doi: 10.1152/ajpendo.00437.2016. Epub 2017 Feb 21. 2017
9ADRB3
β3 adrenergic receptor in the kidney may be a new player in sympathetic regulation of renal function.
Procino G, Carmosino M, Milano S, Dal Monte M, Schena G, Mastrodonato M, Gerbino A, Bagnoli P, Svelto M.
Kidney Int 90(3):555-67. doi: 10.1016/j.kint.2016.03.020. Epub 2016 May 17. 2016
10ADRB3
Effects of energy expenditure gene polymorphisms on obesity-related traits in obese children.
Csernus K, Pauler G, Erhardt É, Lányi É, Molnár D.
Obes Res Clin Pract 9(2):133-40. doi: 10.1016/j.orcp.2014.06.001. Epub 2014 Jul 8. 2015
11ADRB1, ADRB3
Differential expression and role of hyperglycemia induced oxidative stress in epigenetic regulation of β1, β2 and β3-adrenergic receptors in retinal endothelial cells.
Safi SZ, Qvist R, Yan GO, Ismail IS.
BMC Med Genomics 7:29. doi: 10.1186/1755-8794-7-29. 2014
12ADRB3
ADRB3 gene promoter DNA methylation in blood and visceral adipose tissue is associated with metabolic disturbances in men.
Guay SP, Brisson D, Lamarche B, Biron S, Lescelleur O, Biertho L, Marceau S, Vohl MC, Gaudet D, Bouchard L.
Epigenomics 6(1):33-43. doi: 10.2217/epi.13.82. 2014
13ADRB3
Functional involvement of β3-adrenergic receptors in melanoma growth and vascularization.
Dal Monte M, Casini G, Filippi L, Nicchia GP, Svelto M, Bagnoli P.
J Mol Med (Berl) 91(12):1407-19. doi: 10.1007/s00109-013-1073-6. Epub 2013 Aug 2. 2013
14ADRB3, SELE
β3-Adrenergic receptor stimulation induces E-selectin-mediated adipose tissue inflammation.
Roth Flach RJ, Matevossian A, Akie TE, Negrin KA, Paul MT, Czech MP.
J Biol Chem 288(4):2882-92. doi: 10.1074/jbc.M112.412346. Epub 2012 Dec 12. 2013
15ADRB3
Interaction with caveolin-1 modulates G protein coupling of mouse β3-adrenoceptor.
Sato M, Hutchinson DS, Halls ML, Furness SG, Bengtsson T, Evans BA, Summers RJ.
J Biol Chem 287(24):20674-88. doi: 10.1074/jbc.M111.280651. Epub 2012 Apr 25. 2012
16ADRB3
Dependence of β3-adrenergic signaling on the adipokine leptin in cardiac myocytes.
Larson JE, Rainer PP, Watts VL, Yang R, Miller KL, Phan A, Barouch LA.
Int J Obes (Lond) 36(6):876-9. doi: 10.1038/ijo.2011.137. Epub 2011 Jul 19. 2012
17ADRB3
Are there functional β₃-adrenoceptors in the human heart?
Michel MC, Harding SE, Bond RA.
Br J Pharmacol 162(4):817-22. doi: 10.1111/j.1476-5381.2010.01005.x. Review. 2011
18ADRB2, ADRB3
beta2- and beta3-, but not beta1-adrenergic receptors are involved in osteogenesis of mouse mesenchymal stem cells via cAMP/PKA signaling.
Li H, Fong C, Chen Y, Cai G, Yang M.
Arch Biochem Biophys 496(2):77-83. doi: 10.1016/j.abb.2010.01.016. Epub 2010 Feb 4. 2010
19ADRB3
Signaling pathways mediating beta3-adrenergic receptor-induced production of interleukin-6 in adipocytes.
Tchivileva IE, Tan KS, Gambarian M, Nackley AG, Medvedev AV, Romanov S, Flood PM, Maixner W, Makarov SS, Diatchenko L.
Mol Immunol 46(11-12):2256-66. doi: 10.1016/j.molimm.2009.04.008. Epub 2009 May 23. 2009
20ADRB3
beta3-adrenergic receptor activation increases human atrial tissue contractility and stimulates the L-type Ca2+ current.
Skeberdis VA, Gendviliene V, Zablockaite D, Treinys R, Macianskiene R, Bogdelis A, Jurevicius J, Fischmeister R.
J Clin Invest 118(9):3219-27. doi: 10.1172/JCI32519. 2008
21ADRB3
A novel missense mutation in ADRB3 increases risk for type 2 diabetes in a Mexican American family.
Lehman DM, Hamlington J, Hunt KJ, Leach RJ, Arya R, Abboud H, Duggirala R, Blangero J, Goring HH, Stern MP.
Diabetes Metab Res Rev 22(4):331-6. 2006
22ADRB3, GNB3, ADRB2
Impact of variation in ADRB2, ADRB3, and GNB3 genes on body mass index and waist circumference in a Brazilian population.
Mattevi VS, Zembrzuski VM, Hutz MH.
Am J Hum Biol 18(2):182-6. 2006
23ADRB3
Beta 3 adrenergic receptor Trp64Arg polymorphism and manifestation of coronary artery disease in Arabs.
Abu-Amero KK, Al-Boudari OM, Mohamed GH, Dzimiri N.
Hum Biol 77(6):795-802. 2005
24ADRB2, ADRB3, UCP1
Common variants in beta2- and beta3-adrenergic receptor genes and uncoupling protein 1 as predictors of the risk for type 2 diabetes and body weight changes. The Finnish Diabetes Prevention Study.
Salopuro T, Lindstrom J, Eriksson JG, Valle TT, Hamalainen H, Ilanne-Parikka P, Keinanen-Kiukaanniemi S, Tuomilehto J, Laakso M, Uusitupa M.
Clin Genet 66(4):365-7. No abstract available. 2004
25ADRB3
Association of Trp64Arg beta 3-adrenergic-receptor gene polymorphism with essential hypertension in the Sardinian population.
Tonolo G, et al.
J Hypertens 17(1):33-8. 1999
26ADRB3
A quantitative trait locus influencing BMI maps to the region of the beta-3 adrenergic receptor.
Mitchell BD, Cole SA, Comuzzie AG, Almasy L, Blangero J, MacCluer JW, Hixson JE.
Diabetes 48(9):1863-7 1999
27ADRB3, QTLBF2
A paired sibling analysis of the beta-3 adrenergic receptor and obesity in Mexican Americans.
Mitchell BD, Blangero J, Comuzzie AG, Almasy LA, Shuldiner AR, Silver K, Stern MP, MacCluer JW, Hixson JE.
J Clin Invest 101(3):584-7. 1998
28ADRB3
Association of the Trp64Arg mutation of the beta3-adrenergic receptor with fatty liver and mild glucose intolerance in Japanese subjects.
Shima Y, et al.
Clin Chim Acta 274 : 167-176. 1998
29ADRB3, GNRH1, NRG1
Analysis of CA repeat polymorphisms places three human gene loci on the 8p linkage map.
Bruskiewich R, et al.
Cytogenet Cell Genet 73 : 331-333. 1996
30ADRB3
Trp64Arg mutation in beta3-adrenoceptor gene of doubtful significance for obesity and insulin resistance.
Maurige P, et al.
Lancet 348 : 698-699. 1996
31ADRB3
The Trp64Arg mutation of the beta3 adrenergic receptor gene has no effect on obesity phenotypes in the QuŽbec family study and Swedish obese subjects cohorts.
Gagnon J, et al.
J Clin Invest 98 : 2086-2093. 1996
32ADRB3
Association of Trp64Arg mutation of the beta 3-adrenergic receptor gene with NIDDM, current and maximal body mass index.
Yoshioka K, et al.
Diabetologia 39 : 1410-1411. 1996
33ADRB3, GYS2, IRS1
UKPDS 19 : heterogeneity in NIDDM : separate contributions of IRS-1 and beta3-adrenergic-receptor mutations to insulin resistance and obesity respectively with no evidence for glycogene synthase gene mutations.
Zhang Y, et al.
Diabetologia 39 : 1505-1511. 1996
34ADRB3
A mutation in the beta3-adrenergic receptor gene is associated with obesity and hyperinsulinemia in Japenese subjects.
Kadowaki H, et al.
Biochem Biophys Res Commun 215 : 555-560. 1995
35ADRB3
Time of onset of non-insulin-dependent diabetes mellitus and genetic variation in the beta3-adrenergic-receptor gene.
Walston J, et al.
N Engl J Med 333 : 343-347. 1995
36ADRB3
Association of a polymorphism in the beta3-adrenergic-receptor gene with features of the insulin resistance syndrome in Finns.
WidŽn E, et al.
N Engl J Med 333 : 348-351. 1995
37ADRB3
Genetic variation in the beta3-adrenergic receptor and an increased capacity to gain weight in patients with morbid obesity.
ClŽment K, et al.
N Engl J Med 333 : 352-354. 1995
38ADORA3, ADRB3, HTR1B, DRD5
Identification, chromosomal location, and genome organization of mammalian G-protein-coupled receptors.
Wilkie TM, et al.
Genomics 18 : 175-184. 1993